OCATA THERAPEUTICS, INC. (OCAT) financial statements (2021 and earlier)

Company profile

Business Address 33 LOCKE DRIVE
MARLBOROUGH, MA 01752
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments427
Cash and cash equivalents427
Receivables0  
Prepaid expense 1
Prepaid expense and other current assets0
Other undisclosed current assets000
Total current assets:538
Noncurrent Assets
Property, plant and equipment110
Prepaid expense00
Deferred costs 01
Prepaid expense and other noncurrent assets0
Other undisclosed noncurrent assets000
Total noncurrent assets:111
TOTAL ASSETS:648
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities466
Accounts payable123
Accrued liabilities343
Debt 20
Derivative instruments and hedges, liabilities0 1
Estimated litigation liability247
Deferred revenue and credits000
Other liabilities  6
Other undisclosed current liabilities(0)112
Total current liabilities:62322
Noncurrent Liabilities
Long-term debt and lease obligation 1 
Long-term debt, excluding current maturities 1 
Liabilities, other than long-term debt222
Deferred revenue and credits222
Other undisclosed noncurrent liabilities115
Total noncurrent liabilities:347
Total liabilities:82629
Stockholders' equity
Stockholders' equity attributable to parent, including:(3)(23)(22)
Common stock032
Additional paid in capital346323290
Accumulated deficit(349)(314)(282)
Warrants and rights outstanding001
Other undisclosed stockholders' equity attributable to parent(0)(34)(33)
Other undisclosed stockholders' equity  2
Total stockholders' equity:(3)(23)(20)
TOTAL LIABILITIES AND EQUITY:648

Income statement (P&L) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
000
Cost of revenue(0)(0)(0)
Other undisclosed gross profit(0)(0)(0)
Gross profit:000
Operating expenses(35)(30)(21)
Operating loss:(35)(30)(21)
Nonoperating income (expense)0(1)(7)
Investment income, nonoperating0  
Other nonoperating expense(0)  
Interest and debt expense(0)0(4)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes0(0)4
Loss from continuing operations before income taxes:(35)(31)(29)
Income tax expense(16)  
Net loss:(51)(31)(29)
Other undisclosed net income attributable to parent16  
Net loss attributable to parent:(35)(31)(29)
Preferred stock dividends and other adjustments(2)(0)(0)
Net loss available to common stockholders, diluted:(37)(31)(29)

Comprehensive Income ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Net loss:(51)(31)(29)
Comprehensive loss, net of tax, attributable to parent:(51)(31)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: